{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:51:29Z","timestamp":1790772689689,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81102689"],"award-info":[{"award-number":["81102689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbadis.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T20:40:27Z","timestamp":1468701627000},"page":"1883-1890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Baicalein inhibits \u03b1-synuclein oligomer formation and prevents progression of \u03b1-synuclein accumulation in a rotenone mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"1862","author":[{"given":"Qi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuntai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pan-Montojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.07.008_bb0005","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson's disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2011.02.018","article-title":"Parkinson's disease: the non-motor issues","volume":"17","author":"Chaudhuri","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","article-title":"The progression of pathology in Parkinson's disease","volume":"1184","author":"Halliday","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0030","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E","article-title":"Synucleins in synaptic plasticity and neurodegenerative disorders","volume":"58","author":"Clayton","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138920309789351921","article-title":"Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein","volume":"10","author":"Uversky","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0045","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of alpha-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0050","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of alpha-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0060","doi-asserted-by":"crossref","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","article-title":"alpha-Synuclein oligomers impair neuronal microtubule-kinesin interplay","volume":"288","author":"Prots","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0070","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0080","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1042\/BST0331106","article-title":"Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy","volume":"33","author":"Paleologou","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0085","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pbb.2009.03.008","article-title":"Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro","volume":"92","author":"Mu","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0090","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1021\/jf301511m","article-title":"Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1\/Nrf2\/HO-1 and involving PKCalpha and PI3K\/AKT signaling pathways","volume":"60","author":"Zhang","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0095","doi-asserted-by":"crossref","first-page":"14726","DOI":"10.3390\/molecules181214726","article-title":"Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression","volume":"18","author":"Wang","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0100","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmb.2008.08.039","article-title":"Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein","volume":"383","author":"Hong","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cbic.201000604","article-title":"Baicalein inhibits formation of alpha-synuclein oligomers within living cells and prevents Abeta peptide fibrillation and oligomerisation","volume":"12","author":"Lu","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2010.06752.x","article-title":"Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism","volume":"114","author":"Jiang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","article-title":"Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism","volume":"123","author":"Tillerson","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","article-title":"Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice","volume":"2","author":"Pan-Montojo","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jcb.24445","article-title":"Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1\/2 signaling","volume":"114","author":"Zong","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jep.2014.08.031","article-title":"Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects","volume":"156","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2014.11.014","article-title":"Baicalein pretreatment protects against liver ischemia\/reperfusion injury via inhibition of NF-kappaB pathway in mice","volume":"24","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0150","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0155","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s10753-013-9703-2","article-title":"Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-kappaB-dependent pathways","volume":"36","author":"Fan","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.imbio.2006.02.002","article-title":"Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C\/EBPbeta DNA-binding activity","volume":"211","author":"Woo","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbadis.2016.07.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.86","article-title":"Inhibition of 12\/15-lipoxygenase by baicalein induces microglia PPARbeta\/delta: a potential therapeutic role for CNS autoimmune disease","volume":"4","author":"Xu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0170","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3858\/emm.2010.42.12.084","article-title":"Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction","volume":"42","author":"Choi","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.lfs.2012.05.005","article-title":"Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism","volume":"91","author":"Yu","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-004-0213-0","article-title":"Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons","volume":"112","author":"Li","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2016.07.008_bb0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.2011.01228.x","article-title":"Flavonoid modulation of GABA(A) receptors","volume":"163","author":"Hanrahan","year":"2011","journal-title":"Br. J. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T05:49:39Z","timestamp":1549777779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916301685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0925443916301685"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.008","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baicalein inhibits \u03b1-synuclein oligomer formation and prevents progression of \u03b1-synuclein accumulation in a rotenone mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}